U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07938697) titled 'Development and Testing of a Brief Tool to Assess Breakthrough Cancer Pain in Taiwan' on Nov. 10.

Brief Summary: This study aims to develop and test a brief tool called the Breakthrough Cancer Pain Assessment (BCPA) for use with cancer patients in Taiwan. The tool is intended to help medical staff assess episodes of breakthrough cancer pain in busy clinical settings.

The study has three stages. First, 14 clinical experts will review an initial set of 11 questions and assess whether they are relevant and important. Second, two medical staff members will separately interview each of 30 patients within three hours on the same day and ...